Some toughts after the CC

New Post Public Reply Private Reply Replies (0) Message Board
TechGuru
319
I wanted to share my thoughts sometime after the CC as time itself provides some clearer answers.

We desperately needed a deal and we got one. The best one ? No, I am sure there are better and worse alternatives; but we got what we could. I don’t think CYDY is or was in a condition to make demands. We needed help and one gets it from whomever.

We have a contract that, theoretically will protect us from miss-behavior form Vyera (if any). But the important point here is that we need to keep on going … and this allows us to do just that.

If one does not like it there is no good reason to go bananas (as some have done), either get out (today would be a good day to do so), or appreciate that, what was negotiated could be just a (very) little piece of the pie, potentially a large one. This is JUST HIV for USA for Pete’s sake. This deal will give credibility to CDY in the face of potential international partners, if not now, when FDA says that we have a drug and we start selling Lero.

We just survived to fight another day. And this will come.

Without extending too much and going to the details there is not much to say as the appendix will show us “the devil”. However, 50% of “gross profit margin” is not a bad deal at all (maybe a larger company would had negotiated for 15%-20%), some of you say that there are no details, true. Let’s wait for them before jumping up and down. If done in good faith the end result will be close to 50% of what is left once COGS is taken out (for both parties). The lawyers I am sure have thought about this one and nobody will be taking advantage of the other.

Which bring us to sales, what I see is a “hungry” company with loses in the last couple of years. They will be happy to receive something they can actually sell and start profiting (their fate is tied to ours). Hopefully they will be able to ramp-up their sales team rapidly need will be.

The critical point here is PRICING. This is very complicated in light of potential Oncology (and Mono) implications. I wouldn’t’ like to be in the pants of those that have to make a decision that will have implications in the order of 100’s of millions. Too high of a price, less sales and lower potential profit. Too low, less profit. The thing is I don’t believe neither company currently has enough data to make a reasonable good decision. So it will be what it will be. I only hope CYDY has a big saying in this.

We have become so used to extraordinary news that MS didn’t even register in the radar. Does anybody remember Dr. Dennis Berger carefully explaining to a very anxious crowd his progress in MS and the fact that a P2 protocol (similar to Biogen’s Tysabri) is ready? I don’t want to insult anybody’s intelligence by saying this is BIG news … but, what do we do?? Go bananas and start crying foul foul !!!.

We got a deal, maybe with the Devil, but as my dad used to tell me: “one can make deals with the devil provided one knows is the Devil”. This is for a small portion of (hopefully) a very large cake, so, let’s be grateful we can continue walking to find our pot of gold at the end of the rainbow.

BTW: 87 Million (milestones) for a company of a MC of 140 Million should mean $0.6 share in improved valuation so “normally” we should be hovering close to $1. Normally I said

Everybody have a great Holiday Season and a very Happy Christmas !!!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 139

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 121

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 92

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Market Sentiment Around Primerica's Stock

Updated Category News Views 89

Market Sentiment and Primerica's Stock Insights Primerica (NYSE: PRI) has seen a notable change in its short interest recently. The short percent of float has decreased by 11.7% since the last reporting period, indicating a shift in trader sentiment. Currently, there are approximately 219 thousand shares sold short, which accounts for about 0.83% of all regular shares...

Continue Reading
Applied Digital Corporation Secures Major $5 Billion Contract

Updated Category News Views 189

Applied Digital Corporation Celebrates New Milestone Applied Digital Corporation (NASDAQ: APLD) has secured a transformative contract that shines a spotlight on its ambitious Polaris Forge 2 Campus project. The deal, valued at a staggering $5 billion, involves a 15-year lease agreement with a U.S.-based investment-grade hyperscaler. This significant venture is poised to...

Continue Reading
Carnival Cruise Lines on Track for Major Gains in 2025

Updated Category News Views 611

Carnival Cruise Lines Poised for Growth in 2025 Carnival Cruise Lines (NYSE: CCL) has seen a remarkable increase in its share price, rising by approximately 50% as we head into 2024. This upward trend reflects a resilient business model and robust operational efficiencies. Expectations for fiscal 2025 are bolstered by the ongoing normalization of the cruise industry...

Continue Reading
CAS Space Chairman Aims to Build Rockets Like Cars

Updated Category News Views 24

Rocket Science on the Fast Lane Welcome to a new chapter in the space race, where Yang Yiqiang of CAS Space is steering the vision. When you think of rockets, you might imagine a symphony of math and metal, far removed from the everyday grind of car production. But Yang, itching to shuffle that status quo, wants rockets rolling off assembly lines like cars—an idea...

Continue Reading
Vodafone's Strategic Cash Tender Offers Announced for 2025-2028 Bonds

Updated Category News Views 507

Vodafone Group Initiates Cash Tender Offers for Outstanding Notes Vodafone Group Plc, a prominent telecommunications company, has announced its plans to launch cash tender offers for its outstanding U.S. dollar notes due in 2025 and 2028. This strategic move is aimed at managing its debt efficiently, particularly focusing on reducing near-term maturities that could impact...

Continue Reading